NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI): Clinical Trials

4 trials for NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 2, Completed 1, Not yet recruiting 1

Follow NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI): new trials by email Literature Review of NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) trials Research Report on NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Aspirin 100 mg, Clopidogrel 75 mg, Rivaroxaban 15 mg - Coronary Artery Ectasia, Acute Coronary Syndromes (ACS)
Phase 4RecruitingInstituto Nacional de Cardiologia Ignacio Chavez3262026-02-112026-04-09
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Recaticimab - STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Phase 4Not yet recruitingSecond Affiliated Hospital of Nanchang University24422026-01-012025-12-18
Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction
Aspirin, Fondaparinux Sodium - NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI)
Phase 4RecruitingUniversity of Aarhus50762025-05-012026-05-04
Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction
Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia - Acute Myocardial Infarction (AMI), STEMI - ST Elevation Myocardial Infarction (MI)
Phase 4CompletedYoga Yudhistira402024-09-212025-02-27

Narrower conditions

ST Elevation Myocardial Infarction (3)  ·  Acute Coronary Syndrome (1)  ·  Coronary Aneurysm (1)  ·  Ischemia (1)  ·  Non-ST Elevated Myocardial Infarction (1)  ·  Spinocerebellar Ataxias (1)

Broader conditions

Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Infarction (3)  ·  Ischemia (3)  ·  Myocardial Infarction (3)  ·  Myocardial Ischemia (3)  ·  Necrosis (3)  ·  Vascular Diseases (3)  ·  Aneurysm (1)  ·  Ataxia (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebellar Ataxia (1)

Interventions

Aspirin (2)  ·  Clopidogrel (1)  ·  Fondaparinux (1)  ·  Rivaroxaban (1)  ·  dapagliflozin (1)

Sponsors

Instituto Nacional de Cardiologia Ignacio Chavez (1)  ·  Second Affiliated Hospital of Nanchang University (1)  ·  University of Aarhus (1)  ·  Yoga Yudhistira (1)

Countries

Denmark (1)  ·  Indonesia (1)  ·  Mexico (1)

Top investigators

Ahmad Yasa MD (1)  ·  Yoga Yudhistira MD (1)

Results publications

PMID 11277825, PMID 15007110, PMID 17394957, PMID 21067804, PMID 30264159, PMID 31000179, PMID 31117810, PMID 31479722, PMID 32938773, PMID 34785173, PMID 35019162, PMID 35368058, PMID 36100012, PMID 36779348, PMID 37622654, PMID 38211676, PMID 38788773, PMID 39126262, PMID 40014670, PMID 40945808